{"url_path":"/sec/nxtc/8-k/2026-06-25/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 ****Financial Statements and Exhibits**","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-06-25","source_url":"https://www.sec.gov/Archives/edgar/data/1661059/0001104659-26-077546-index.html","accession_number":"0001104659-26-077546","cik":"0001661059","ticker":"NXTC","issuer_name":"NextCure, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1661059/0001104659-26-077546-index.html","primary_entity_key":"0001661059","primary_entity_name":"NextCure, Inc."},"word_count":101,"has_tables":true,"body_markdown":"**Item 9.01****Financial Statements and Exhibits**\n\n(d) Exhibits\n\n​\n\n​\n\n​\n\n​\n\n​\n\n​\n\n​\n\n​\n\n**Exhibit No.**\n\n​\n\n**Description**\n\n[10.1](nxtc-20260618xex10d1.htm)\n\n​\n\n[NextCure, Inc. Amended and Restated 2019 Omnibus Incentive Plan](nxtc-20260618xex10d1.htm)\n\n104\n\n​\n\nCover Page Interactive Data File (formatted as inline XBRL)\n\n​\n\n​\n\n​\n\n**SIGNATURE**\n\n \n\nPursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.\n\n \n\n \n\nNovember\n\nDated: June 25, 2026\n\n**NEXTCURE, INC.**\n\n​\n\n \n\n \n\n \n\n \n\nBy:\n\n/s/ Steven P. Cobourn\n\n \n\nName:\n\nSteven P. Cobourn\n\n \n\nTitle:\n\nChief Financial Officer\n\n​\n\n​\n\n​\n\n​\n\n​"}